Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Director/PDMR Shareholding

14 Mar 2023 16:16

RNS Number : 9601S
Tyman PLC
14 March 2023
 

TYMAN PLC

("Tyman" or the "Company" or the "Group")

 

DIRECTOR/PDMR SHAREHOLDINGS

 

Tyman plc announces that it has been notified of the following transactions in the Company's ordinary 5p shares ("Ordinary Shares") undertaken by the Executive Directors and PDMRs, Jo Hallas, CEO and Jason Ashton, CFO.

 

DEFERRED SHARE BONUS PLAN (THE "DSBP")

 

On 10 March 2023 the following shares were awarded in respect of the year ended31 December 2022 (the "2022 Awards") under the Company's DSBP, in the form of nil cost options.

Name

Shares awarded1

Jo Hallas

36,875

Jason Ashton

19,245

1 Number of shares calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 9th March 2023) of £2.461.

 

Under the Company's annual bonus scheme, 50% of Executive Director bonuses that would otherwise have been payable in cash are instead delivered as deferred shares under the DSBP.

 

These awards will normally vest (together with dividend equivalents in cash or Ordinary Shares) following the publication of the Group's audited results for the year ending31 December 2025, expected to be in March 2026. No consideration was paid for the 2022 Awards and no consideration is due to be payable on vesting.

 

LONG TERM INCENTIVE PLAN (THE "LTIP")

On 10 March 2023 ("Award Date"), the following shares were awarded under the Company's LTIP, in the form of nil cost options (the "2023 Awards"):

Name

Shares awarded1

Jo Hallas

351,991

Jason Ashton

183,705

1 Number of shares calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 9th March 2023) of £2.461.

 

Performance conditions

 

The vesting of the 2023 Awards is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company, as disclosed in the 2022 Annual Report and Accounts, to be published on 3 April 2023. Awards granted to the Executive Directors that vest shall be subject to a compulsory holding period of five years from the Award Date.

 

2023 Awards are expected to vest in March 2026, following the announcement of the Company's results for the year ended 31 December 2025, subject to fulfilment of the performance conditions and continued employment in the Group, and the holding requirement is expected to expire in March 2028.

 

Timetable and Awards Outstanding

 

The details of the Awards are set out below:

1

 

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

 

Names

 

i. JO HALLAS

ii. JASON ASHTON

 

2

 

Reason for the notification: AWARD OF OPTIONS

 

a)

 

Position/status

 

i. CHIEF EXECUTIVE OFFICER

ii. CHIEF FINANCIAL OFFICER

 

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

TYMAN PLC

b)

 

LEI

 

213800AAFUV5PKGQU848

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

 

Identification code

ISIN NUMBER:GB00B29H4253

b)

 

Nature of the transaction

NIL COST OPTIONS GRANTED UNDER TYMAN PLC DEFERRED SHARE BONUS PLAN

c)

Prices (s) and volume(s)

Price

Volume

i.

Nil

36,875

ii.

Nil

19,245

d)

 

Aggregated information

- Aggregated volume

- 56,120

 

- Price

- Nil

e)

 

Date of the transaction

 

10 March 2023

f)

 

Place of the transaction

OUTSIDE OF TRADING VENUE

1

 

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

 

Names

 

i. JO HALLAS

ii. JASON ASHTON

 

2

 

Reason for the notification: AWARD OF OPTIONS

 

a)

 

Position/status

 

i. CHIEF EXECUTIVE OFFICER

ii. CHIEF FINANCIAL OFFICER

 

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

TYMAN PLC

b)

 

LEI

 

213800AAFUV5PKGQU848

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

 

Identification code

ISIN NUMBER:GB00B29H4253

b)

 

Nature of the transaction

NIL COST OPTIONS GRANTED SUBJECT TO PERFORMANCE CONDITIONS UNDER TYMAN PLC LONG TERM INCENTIVE PLAN

c)

Prices (s) and volume(s)

Price

Volume

i.

Nil

351,991

ii.

Nil

183,705

d)

 

Aggregated information

- Aggregated volume

- 535,696

 

- Price

- Nil

e)

 

Date of the transaction

 

10 March 2023

f)

 

Place of the transaction

OUTSIDE OF TRADING VENUE

 

This disclosure is made in accordance with Article 19 of EU Market Abuse Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

 

14 March 2023

 

 

 

Enquiries:

Tyman plc

020 7976 8000

Peter Ho - General Counsel & Company Secretary

www.tymanplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQZLFFXXLFBBX
Date   Source Headline
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group
24th May 20213:22 pmRNSDirector/PDMR Shareholding
20th May 20214:39 pmRNSResult of AGM
20th May 20217:00 amRNSCapital Markets Event
13th May 20214:45 pmRNSHolding(s) in Company
11th May 20214:38 pmRNSHolding(s) in Company
10th May 20214:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.